Senior Director, CMC and Allogeneic Cell Therapy Program Lead at Umoja Biopharma - Seattle, WA, US
Umoja is developing a new approach to cancer therapy that retools a patient's immune system in vivo, enhancing the body's natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.